213156 Building the “Medical Home” Without Walls: A new team approach to managing Diabetes with pharmacists, podiatrists, optometrists and dental professionals

Monday, November 9, 2009: 3:40 PM

W. Lee Ball, OD , Beetham Eye Institute, Joslin Diabetes Center, Boston, MA
Dennis R. Frisch, DPM , American Podiatric Medical Association, Boca Raton, FL
Fueled by obesity, type 2 Diabetes Mellitus is fast becoming an epidemic in the United States. With the push by the current administration for health care reform, it's paramount that the “medical home” is broad based and comprehensive to best care for these patients' needs. Pharmacists, podiatrists, optometrists and dental care (PPOD) professionals are often a primary point of care for people with type 2 diabetes. Data from the Diabetes Control and Complications Trial (DCCT) have been presented extensively. However, this novel approach for team care with PPOD providers has not. Utilization data from a PPOD reporting form will be reported, demonstrating better health outcomes for individuals with diabetes who receive timely foot, eye, and oral health care and medication review. Join this panel of professionals as they discuss diabetes management, promote team care and advocate for the inclusion of pharmacists, podiatrists, optometrists and dentists in the "medical home" model.

Learning Objectives:
Discuss National Diabetes Education Program (NDEP) diabetes prevention messages. Explain the benefit of metabolic control in reducing microvascular complications. Describe the diabetes care issues of the PPOD disciplines and recognize concerns warranting referral . Define annual PPOD screening recommendations for patients with diabetes. Describe how to design multidisciplinary diabetes care teams in communities.

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: coming.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.